Midway through trading Thursday, the Dow traded up 0.09 percent to 15,978.01 while the NASDAQ surged 0.40 percent to 4,218.16. The S&P also rose, gaining 0.19 percent to 1,822.78. Leading and Lagging Sectors ...

Since new Federal Reserve Chairman, Janet Yellen, has taken control, the Dow Jones Industrial Average has skyrocketed, and IPOs averaged up about five percent on Wednesday. Investors and traders are looking ...

Following the market opening Thursday, the Dow traded down 0.36 percent to 15,906.11 while the NASDAQ declined 0.06 percent to 4,198.75. The S&P also fell, dropping 0.24 percent to 1,814.88. Leading and ...

Among the leading biotech and emerging pharmaceutical companies, Incyte (NASDAQ: INCY ) and Pharmacyclics (NASDAQ: PCYC ) saw the largest percentage declines in short interest between the January 15 and ...

The top equity strategist at Merrill Lynch has updated the High Quality and Dividend Yield screen of stocks to buy, adding some names that may provide investors solid 2014 returns.

Dispersion strategies can bring big profits to those with superior stock picking skills.

The equity strategy team at J.P. Morgan presented a new research report that actually makes a very solid case not only for equities, but for equities with higher emerging market exposure. Here are 10 picks ...

Box, which counts Dropbox among its rivals, has reportedly filed to go public.

Friday is a strange day in the markets. The month of January is closing out with the first monthly January loss in three years, after a huge 2013 of course. Yet there were six initial public offerings ...

Six IPOs hit the market Friday , and three of them were biotechs. What stands out is that these emerging pharma deals came on the heels of a wildly successful biotech IPO on Thursday.

January 29, 2014: Markets opened lower on Wednesday following Tuesday’s late policy rate hike by the Turkish government. The announcement that the Fed will again reduce its asset purchases added more volatility ...

As of January 15, short interest in several semiconductor stocks increased as investors continued to bet against PC processors and memory chips in favor of mobile devices. With only a couple of exceptions, ...

We continue to track the short interest changes in the primary 3D printer and services companies. The following information is based on data reported for the period ended January 15, 2014. Short interest ...

The equity research team at Jefferies has come out with a list of their stocks to buy that have been ambushed hard, not only the past two trading days, but since the beginning of the year.

The so-called underwriter quiet period for AMC Entertainment Holdings has come to an end, so now the analysts in the underwriting syndicate firms can issue coverage on the company. Shares were down in ...

Facebook held its initial public offering (IPO) on May 18, 2012. This was seen as one of the biggest IPOs in technology and Internet history.

Jabil Circuit Inc. (NYSE: JBL) is in the unloved field of contract manufacturing, also known as electronic manufacturing services. This sector is not exactly exciting to investors, or at least that was ...

InPlay from Briefing.com

To many investors, online retailing behemoth Amazon (AMZN) is a riddle contained in a mystery, wrapped inside an enigma (with apologies to Mr. Churchill). That’s not the highest Amazon’s multiple has been; You can grumble that Jeff Bezos’s decision to starve Amazon’s bottom line in order to finance its ongoing expansion mean that it’s not shareholder friendly, but even before the publicity around those planned delivery drones, enough investors were willing to buy into the company’s future promise to drive its price up 55 percent in 2013. But, as a team of analysts from Wedbush wrote in a note recently published in Barron's, “Amazon is unlikely to provide investors with a strategy road map.” Moreover, they noted, “it could be a long time before (earnings per share) grows sufficiently to justify its share price.”

The Federal Reserve had been trying for years to persuade investors to take on more risk, and a renewed affection for growth was one of the dominant market characteristics of the year. That may have been because growth stock pricing reached appealing levels as the economy appeared poised to speed up, or, more likely, because absolute growth became more alluring than the razor-thin yields on bonds and the prices for dividend stocks. Either way, growth stocks got hot. Even for a growth stock, that’s rich – but it didn’t stop the company’s stock from rallying 300 percent.